CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Treatment and outcome of genotype 4 chronic hepatitis C patients with pegylated interferon α-2b and ribavirin in a German real-life-setting
DOI 10.1055/s-0030-1269729
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Mauss, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, K Dach, M Bilzer, G Tossing, D Hueppe
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Pegylated interferon (PEG-IFN) α and ribavirin (RBV) are the standard of care for hepatitis C treatment. The efficacy and safety of PEG-IFNα-2b and RBV was observed within a large German real life surveillance study. Methods: Between 9/2003 and 5/2009, a total of 279 sites (71 sites with single and dual genotype 4 patients) have treated a total of 4061 patients. 121 patients (2.9%) were infected with genotype…
Zitieren
Zitierempfehlung
S Mauss, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, K Dach, M Bilzer, G Tossing, D Hueppe (2011) Treatment and outcome of genotype 4 chronic hepatitis C patients with pegylated interferon α-2b and ribavirin in a German real-life-setting. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0030-1269729
Mit CareLit weiterarbeiten